ADVENT On Air | Breath, Blood, and Beyond: The Prognostic Power of Biomarkers in Asthma Across Ages

• Explain how type 2 cytokines may be linked to elevated asthma biomarkers such as blood eosinophils, FeNO, and IgE
• Explore the link between elevated biomarkers and lung function decline, exacerbations, and other applicable features of disease burden in asthma
• Examine the prognostic value of FeNO and blood eosinophils independently and together in asthma
• Discuss current guidelines on recommendations for biomarker assessment in a clinical setting

Gain critical insights into asthma biomarkers with pediatric respirologist Dr. Sharon Dell and adult respirologist Dr. Simon Couillard. This discussion highlights the prognostic and diagnostic significance of FeNO, blood eosinophils, and IgE in identifying Type 2 inflammation, assessing risk for exacerbations and lung function decline, and ultimately, optimizing asthma care across the pediatric and adult spectrum.